Compare Mutual Funds

Pros
Larger AUM within category.

Larger AUM within category.

Beats FD returns for both 3Y & 5Y duration.

Beats FD returns for both 3Y & 5Y duration.

5Y returns in the top 25% of the category.

5Y returns in the top 25% of the category.

3Y returns in the top 25% of the category.

3Y returns in the top 25% of the category.

Among most bought funds within the category.

Among most bought funds within the category.

Cons
5Y returns in the bottom 25% of the category.

5Y returns in the bottom 25% of the category.

3Y returns in the bottom 25% of the category.

3Y returns in the bottom 25% of the category.

-

INDMoney rank
8/8
1/8
Category

Equity, Sector - Healthcare

Equity, Sector - Healthcare

Fund Age

13 Years 10 Months

13 Years 10 Months

Fund AUM

₹9279 Cr

₹5400 Cr

Min Investment
  1. SIP ₹100
  2. Lumpsum ₹5000
  1. SIP ₹500
  2. Lumpsum ₹5000
Expense Ratio

1%

1.02%

Exit Load

1%

0.5%

Benchmark Index

BSE Healthcare TR INR

BSE Healthcare TR INR

No of Holdings

38

36

Top 5 Holdings
  1. Sun Pharmaceuticals Industries Ltd(13.31%)
  2. Lupin Ltd(7.25%)
  3. Divi's Laboratories Ltd(6.52%)
  4. Cipla Ltd(6.03%)
  5. Apollo Hospitals Enterprise Ltd(5.3%)
  1. Sun Pharmaceuticals Industries Ltd(12.72%)
  2. Divi's Laboratories Ltd(7.46%)
  3. Acutaas Chemicals Ltd(5.17%)
  4. Cipla Ltd(5.07%)
  5. Apollo Hospitals Enterprise Ltd(4.98%)
No of Sectors

1

3

Top 3 Sectors

Health

(100%)

  1. Health(92.41%)
  2. Basic Materials(7.59%)
  3. Government(2.09%)
Equity %

97.32%

98.29%

Debt %

-

0.05%

P/E

39.56

50.2

P/B

5.84

6.97

Credit Quality

-

-

Modified Duration

-

-

YTM

-

-

1-Month Return

0.56%

1.47%

3-Month Return

7.79%

13.25%

6-Month Return

12.85%

23.26%

1-Year Return

13.06%

23.08%

3-Year Return

19.19%

24.71%

5-Year Return

13.91%

18.76%

Sharpe

0.89

1.21

Alpha

-1.21

3.34

Beta

0.88

0.86

Standard Deviation

14.77

14.38

Information Ratio

-0.88

0.41

Description

Nippon India Pharma Fund is an equity fund.The fund could potentially beat inflation in the long-run.

SBI Healthcare Opportunities Fund is an equity fund.The fund could potentially beat inflation in the long-run.

Managers

Sailesh Raj Bhan, Kinjal Desai, Amber Singhania

Tanmaya Desai

Most Popular Comparisons